Chinese expert consensus on the diagnosis and treatment of sepsis-induced coagulopathy(2024 edition)
10.11855/j.issn.0577-7402.1189.2024.0918
- VernacularTitle:脓毒症性凝血病诊疗中国专家共识(2024版)
- Author:
Jing-Chun SONG
1
;
Ren-Yu DING
;
Ben LYU
;
Heng MEI
;
Gang WANG
;
Wei ZHANG
;
Jing ZHOU
;
Jun GUO
;
Chinese Society of Thrombosis,Hemostasis and Critical Care,Chinese Medicine Education Association
;
Chinese People's Liberation Army Professional Committee of Critical Care Medicine
Author Information
1. 解放军联勤保障部队第908医院重症医学科,江西 南昌 330002
- Keywords:
sepsis;
coagulopathy;
immunothrombosis;
thromboinflammation;
phenotypes;
anticoagulation
- From:
Medical Journal of Chinese People's Liberation Army
2024;49(11):1221-1236
- CountryChina
- Language:Chinese
-
Abstract:
Sepsis-induced coagulopathy(SIC),a critical and potentially lethal condition arising from sepsis,results in endothelial damage and significant coagulation dysregulation,making it a major factor contributing to mortality among sepsis patients.Early diagnosis and treatment of SIC are expected to improve the prognosis of sepsis patients.In 2019,the International Society on Thrombosis and Hemostasis(ISTH)issued the first guidelines for the diagnosis and treatment of SIC,but there are no corresponding protocols in China.Therefore,Chinese Society of Thrombosis,Hemostasis and Critical Care,Chinese Medicine Education Association,and Chinese People's Liberation Army Professional Committee of Critical Care Medicine jointly formulated the"Chinese Expert Consensus on the Diagnosis and Treatment of Sepsis-induced Coagulopathy(2024 edition)."This consensus includes 5 parts:pathogenesis,classification,laboratory approaches,diagnosis and treatment,with a total of 14 evidence-based recommendations to guide clinical practice.
